CDNS vs PCRX · P/E 82, rev $5.30B vs P/E 174, rev $369.8M
Cadence Design Systems Inc (CDNS) versus Pacira BioSciences, Inc. (PCRX) — a side-by-side from cached financials, not a winner call.
Cadence Design Systems Inc (CDNS) is a software - application company listed on US. It is led by Anirudh Devgan Ph.D..
Pacira BioSciences, Inc. (PCRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CDNS revenue for 2025-12-31 was $5.30B. Net income was $1.11B. Revenue was up 14.1% from 2024-12-31 to 2025-12-31. CDNS currently screens at market cap $88.27B and trailing P/E 82.0.
Latest reported PCRX revenue for 2026-06-30 was $369.8M. Net income was $7.6M. PCRX currently screens at market cap $890.8M and trailing P/E 174.2.
CDNS currently screens at market cap $88.27B and trailing P/E 82.0. PCRX currently screens at market cap $890.8M and trailing P/E 174.2.
Not investment advice. Open the CDNS and PCRX stock pages for the full models.
Not investment advice.